GE HealthCare Technologies (GEHC) Gross Margin (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported Gross Margin for 5 consecutive years, with 41.17% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Margin rose 153.0% year-over-year to 41.17%; the trailing twelve-month figure through Jun 2026 stood at 39.54% (down 203.0% YoY), and the FY2025 full-year result was 39.99%, down 172.0% from the prior year.
• Gross Margin climbed to 41.17% in Q2 2026 per GEHC's latest filing, from 38.53% in the prior quarter.
• Across five years, Gross Margin topped out at 42.77% in Q4 2024 and bottomed at 38.53% in Q1 2026.
• Historically, Gross Margin has averaged 40.28% across 5 years, with a median of 40.15% in 2023.
• The sharpest annual moves came in 2023 and 2026: Gross Margin surged 229 bps in 2023, then sank 359 bps in 2026.
• Over 5 years, Gross Margin stood at 39.13% in 2022, then gained by 6 bps to 41.41% in 2023, then grew by 3 bps to 42.77% in 2024, then retreated by 7 bps to 39.68% in 2025, then rose by 4 bps to 41.17% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 41.17%, 38.53%, and 39.68% for Q2 2026, Q1 2026, and Q4 2025 respectively.